VAERS Reports UJ73AA

VAERS 1935436

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ73AA

mild

Staat: CA
Alter: -
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 30.08.2021
Beginn: 30.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Injection site pain Neck pain

Symptomtext

Pt describes pain in shoulder/neck that started day after injection . She went to ER on 9/18/21 . Pain worsened on day 4 . Pain in injection site on deltoid resolved within 4 days & started evening of injection day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Unknown
Vorgeschichte: -
Andere Medikamente: Unknown
Allergien: N/A
Vorherige Impfungen: -

VAERS 2703559

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ73AA

gering

Staat: TX
Alter: 1,0
Geschlecht: F
Eingang: 27.10.2023
Impfdatum: 17.10.2023
Beginn: 17.10.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

received an expired hib vaccine with no reported adverse event; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 1 years old female patient who experienced received an expired HIB (PRP/T) vaccine [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria, Tetanus and Acellular pertussis vaccine (Daptacel) for Immunisation; and Pneumococcal vaccine CONJ 15V (CRM197) (Vaxneuvance) for Prophylactic vaccination. On 17-Oct-2023, the patient received an expired 0.5 ml dose of suspect HIB (PRP/T) vaccine (frequency: once; Strength: standard) Powder and solvent for solution for injection of lot UJ73AA and expiry: 07-Oct-2023 via intramuscular route in the left vastus lateralis for immunization, with no reported adverse event (expired product administered) (latency: same day). No lab data was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: DAPTACEL; VAXNEUVANCE
Allergien: -
Vorherige Impfungen: -